← Evidence map

ReviewFrontiers in cell and developmental biology2023

CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective.

Fiona H Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

37 papers cite it

2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37035239